Prolonged Infectiousness of Tuberculosis Patients in a Directly Observed Therapy Short‐Course Program with Standardized Therapy

dc.contributor.authorSean Fitzwater
dc.contributor.authorLuz Caviedes
dc.contributor.authorRobert H. Gilman
dc.contributor.authorJorge Coronel
dc.contributor.authorDoris LaChira
dc.contributor.authorCayo Salazar
dc.contributor.authorJuan Carlos Saravia
dc.contributor.authorKrishna P. Reddy
dc.contributor.authorJon S. Friedland
dc.contributor.authorDavid Moore
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:04:39Z
dc.date.available2026-03-22T14:04:39Z
dc.date.issued2010
dc.descriptionCitaciones: 68
dc.description.abstractSmear and culture conversion in treated tuberculosis patients takes longer than is conventionally believed, even with fully susceptible disease, and must be accounted for in tuberculosis treatment and prevention programs. Persistent day 60 smear positivity is a poor predictor of multidrug resistance. The industrialized-world convention of universal baseline DST for tuberculosis patients should become the standard of care in multidrug resistance-affected resource-limited settings.
dc.identifier.doi10.1086/655127
dc.identifier.urihttps://doi.org/10.1086/655127
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/44406
dc.language.isoen
dc.publisherOxford University Press
dc.relation.ispartofClinical Infectious Diseases
dc.sourceJohns Hopkins University
dc.subjectMedicine
dc.subjectTuberculosis
dc.subjectCulture conversion
dc.subjectDirectly Observed Therapy
dc.subjectInternal medicine
dc.subjectMycobacterium tuberculosis
dc.subjectDrug resistance
dc.subjectSurgery
dc.titleProlonged Infectiousness of Tuberculosis Patients in a Directly Observed Therapy Short‐Course Program with Standardized Therapy
dc.typearticle

Files